Warning signs could predict inflammatory bowel disease a decade before diagnosis

by | Oct 21, 2026 | Science

Warning signs could predict inflammatory bowel disease a decade before diagnosis

Scientists have identified immune system markers that may predict inflammatory bowel disease a decade prior to symptom onset, according to findings published in the journal Gut and presented at a major gastroenterology conference in Barcelona.

The research examined blood samples collected from US military personnel, analyzing 2,000 samples from 500 individuals. Of these, 200 participants later developed Crohn’s disease, 200 developed ulcerative colitis, and 100 developed neither condition. Researchers screened the samples for antibodies produced in response to various protein fragments from bacteria, viruses, food sources, and the body’s own tissues.

Results revealed distinct immune patterns associated with each form of inflammatory bowel disease. In those who eventually developed Crohn’s disease, antibodies against Epstein-Barr virus appeared more frequently, with detectable differences evident a decade before diagnosis. The signal was particularly pronounced in patients who subsequently developed more severe disease manifestations. Individuals who developed ulcerative colitis displayed a different antibody pattern, including responses against the body’s own proteins.

Inflammatory bowel disease affects approximately 3.8 million people worldwide and is characterized by chronic gut inflammation causing pain, diarrhea, and fatigue. Current treatment approaches rely on anti-inflammatory and immune-suppressing medications, though many patients show limited response, and surgical intervention is sometimes necessary. Researchers hope earlier detection could enable intervention before intestinal damage occurs, potentially preventing the development of disease altogether.

Experts caution that additional validation in other populations is required before clinical application. While the findings demonstrate a link between immune markers and disease development, further research must confirm causality. The work follows a similar model used in type 1 diabetes detection, where early immune system changes can be identified before symptoms manifest.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI